On March 28, the 2019 China (Chengdu) Health Care Investment and Development Seminar and the 2018 China Health Care Investment Report Launching Ceremony jointly initiated by Chengdu Hi-tech Zone Biological Industry Development Bureau and Hsmap was held in Chengdu Hi-tech Zone. Representatives of leading health care investors such as Huagai, GTJA and InvestKorea, and senior executives of local enterprises such as Hitgen and Hinova gathered to discuss the development of the industry.

The 2018 Investment Report on China’s Health Care Industry released at the meeting showed that 23 financing cases were completed in Sichuan’s health care industry last year, up 35.3% year on year, with more than 95% of them occurring in Chengdu.

Bio-industry Circle of Funding Friends Road Show Base unveiled in Chengdu Hi-tech Zone

At the event site, Chengdu Hi-tech Zone established partnerships with more than 20 domestic top bio-industry professional equity investment institutions and unveiled the nameplate “Chengdu Hi-tech Zone Bio-industry Circle of Funding Friends Roadshow Base” at the Chengdu Advanced Medical Science Center.

In the future, investment institutions participating in the cooperation will set aside an investment quota of RMB 1 billion per year for the high-quality bio-industry projects in Chengdu High-tech Zone to jointly promote the bio-industry in Chengdu. Representatives of the Chengdu Hi-tech Zone Bio-industry Development Bureau said that they would create more opportunities and conditions, actively promote exchanges and cooperation between project runners, investment institutions and innovative technology providers, accelerate the construction of the bio-industry ecosystem and the bio-industry functional zone, and further promote the high-quality development of Chengdu’s bio-industry.